Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells.
Identifieur interne : 000686 ( Ncbi/Curation ); précédent : 000685; suivant : 000687Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells.
Auteurs : Andis Klegeris [Canada] ; Benoit I. Giasson ; Hong Zhang ; John Maguire ; Steven Pelech ; Patrick L. McgeerSource :
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology [ 1530-6860 ] ; 2006.
English descriptors
- KwdEn :
- Astrocytes (metabolism), Astrocytes (pathology), Astrocytoma (metabolism), Astrocytoma (pathology), Cell Line, Tumor, Gene Expression Regulation, Genetic Predisposition to Disease, Humans, Inflammation, Intercellular Adhesion Molecule-1 (genetics), Interleukin-6 (genetics), MAP Kinase Signaling System, Mutation, Missense, Temporal Lobe (pathology), Tumor Cells, Cultured, Up-Regulation (genetics), alpha-Synuclein (genetics), alpha-Synuclein (physiology).
- MESH :
- chemical , genetics : Intercellular Adhesion Molecule-1, Interleukin-6, alpha-Synuclein.
- genetics : Up-Regulation.
- metabolism : Astrocytes, Astrocytoma.
- pathology : Astrocytes, Astrocytoma, Temporal Lobe.
- chemical , physiology : alpha-Synuclein.
- Cell Line, Tumor, Gene Expression Regulation, Genetic Predisposition to Disease, Humans, Inflammation, MAP Kinase Signaling System, Mutation, Missense, Tumor Cells, Cultured.
Abstract
Autosomal dominant Parkinson disease (PD) is caused by duplication or triplication of the alpha-synuclein gene as well as by the A30P, E46K, and A53T mutations. The mechanisms are unknown. Reactive astrocytes in the substantia nigra of PD and MPTP-treated monkeys display high levels of the inflammatory mediator intercellular adhesion molecule-1 (ICAM-1), indicating that chronic inflammation contributes to the degeneration. Here we report that alpha-synuclein strongly stimulates human astrocytes as well as human U-373 MG astrocytoma cells to up-regulate both interleukin (IL)-6 and ICAM-1 (ED50=5 microg ml(-1)). The mutated forms are more potent stimulators than wild-type (WT) alpha-synuclein in these assays. We demonstrate by immunoblotting analysis that this up-regulation is associated with activation of the major mitogen-activated protein kinase (MAPK) pathways. It is also attenuated by PD 98059, an inhibitor of the MAPK/extracellular-regulated kinase kinase MEK1/2, SP 600125, an inhibitor of c-Jun N-terminal kinase (JNK), and SB 202190, an inhibitor of p38 MAPK. The inhibitory effects on human astrocytes have IC50 values of 2, 5, and 1.5 microM respectively. We hypothesize that the neuroinflammation stimulated by release of an excess of normal alpha-synuclein or by release of its mutated forms can be involved in the pathobiology of PD.
DOI: 10.1096/fj.06-6183com
PubMed: 17012252
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001138
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001138
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001138
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000686
Links to Exploration step
pubmed:17012252Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells.</title>
<author><name sortKey="Klegeris, Andis" sort="Klegeris, Andis" uniqKey="Klegeris A" first="Andis" last="Klegeris">Andis Klegeris</name>
<affiliation wicri:level="1"><nlm:affiliation>Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada. aklegeri@interchange.ubc.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3</wicri:regionArea>
<wicri:noRegion>BC V6T 1Z3</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Giasson, Benoit I" sort="Giasson, Benoit I" uniqKey="Giasson B" first="Benoit I" last="Giasson">Benoit I. Giasson</name>
</author>
<author><name sortKey="Zhang, Hong" sort="Zhang, Hong" uniqKey="Zhang H" first="Hong" last="Zhang">Hong Zhang</name>
</author>
<author><name sortKey="Maguire, John" sort="Maguire, John" uniqKey="Maguire J" first="John" last="Maguire">John Maguire</name>
</author>
<author><name sortKey="Pelech, Steven" sort="Pelech, Steven" uniqKey="Pelech S" first="Steven" last="Pelech">Steven Pelech</name>
</author>
<author><name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:17012252</idno>
<idno type="pmid">17012252</idno>
<idno type="doi">10.1096/fj.06-6183com</idno>
<idno type="wicri:Area/PubMed/Corpus">001138</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001138</idno>
<idno type="wicri:Area/PubMed/Curation">001138</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001138</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001138</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001138</idno>
<idno type="wicri:Area/Ncbi/Merge">000686</idno>
<idno type="wicri:Area/Ncbi/Curation">000686</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells.</title>
<author><name sortKey="Klegeris, Andis" sort="Klegeris, Andis" uniqKey="Klegeris A" first="Andis" last="Klegeris">Andis Klegeris</name>
<affiliation wicri:level="1"><nlm:affiliation>Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada. aklegeri@interchange.ubc.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3</wicri:regionArea>
<wicri:noRegion>BC V6T 1Z3</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Giasson, Benoit I" sort="Giasson, Benoit I" uniqKey="Giasson B" first="Benoit I" last="Giasson">Benoit I. Giasson</name>
</author>
<author><name sortKey="Zhang, Hong" sort="Zhang, Hong" uniqKey="Zhang H" first="Hong" last="Zhang">Hong Zhang</name>
</author>
<author><name sortKey="Maguire, John" sort="Maguire, John" uniqKey="Maguire J" first="John" last="Maguire">John Maguire</name>
</author>
<author><name sortKey="Pelech, Steven" sort="Pelech, Steven" uniqKey="Pelech S" first="Steven" last="Pelech">Steven Pelech</name>
</author>
<author><name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</analytic>
<series><title level="j">FASEB journal : official publication of the Federation of American Societies for Experimental Biology</title>
<idno type="eISSN">1530-6860</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Astrocytes (metabolism)</term>
<term>Astrocytes (pathology)</term>
<term>Astrocytoma (metabolism)</term>
<term>Astrocytoma (pathology)</term>
<term>Cell Line, Tumor</term>
<term>Gene Expression Regulation</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Inflammation</term>
<term>Intercellular Adhesion Molecule-1 (genetics)</term>
<term>Interleukin-6 (genetics)</term>
<term>MAP Kinase Signaling System</term>
<term>Mutation, Missense</term>
<term>Temporal Lobe (pathology)</term>
<term>Tumor Cells, Cultured</term>
<term>Up-Regulation (genetics)</term>
<term>alpha-Synuclein (genetics)</term>
<term>alpha-Synuclein (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Intercellular Adhesion Molecule-1</term>
<term>Interleukin-6</term>
<term>alpha-Synuclein</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Up-Regulation</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Astrocytes</term>
<term>Astrocytoma</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Astrocytes</term>
<term>Astrocytoma</term>
<term>Temporal Lobe</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>alpha-Synuclein</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cell Line, Tumor</term>
<term>Gene Expression Regulation</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Inflammation</term>
<term>MAP Kinase Signaling System</term>
<term>Mutation, Missense</term>
<term>Tumor Cells, Cultured</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Autosomal dominant Parkinson disease (PD) is caused by duplication or triplication of the alpha-synuclein gene as well as by the A30P, E46K, and A53T mutations. The mechanisms are unknown. Reactive astrocytes in the substantia nigra of PD and MPTP-treated monkeys display high levels of the inflammatory mediator intercellular adhesion molecule-1 (ICAM-1), indicating that chronic inflammation contributes to the degeneration. Here we report that alpha-synuclein strongly stimulates human astrocytes as well as human U-373 MG astrocytoma cells to up-regulate both interleukin (IL)-6 and ICAM-1 (ED50=5 microg ml(-1)). The mutated forms are more potent stimulators than wild-type (WT) alpha-synuclein in these assays. We demonstrate by immunoblotting analysis that this up-regulation is associated with activation of the major mitogen-activated protein kinase (MAPK) pathways. It is also attenuated by PD 98059, an inhibitor of the MAPK/extracellular-regulated kinase kinase MEK1/2, SP 600125, an inhibitor of c-Jun N-terminal kinase (JNK), and SB 202190, an inhibitor of p38 MAPK. The inhibitory effects on human astrocytes have IC50 values of 2, 5, and 1.5 microM respectively. We hypothesize that the neuroinflammation stimulated by release of an excess of normal alpha-synuclein or by release of its mutated forms can be involved in the pathobiology of PD.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000686 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000686 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:17012252 |texte= Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:17012252" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |